sdz 208-912 has been researched along with reserpine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlsson, A; Ekman, A; Hoffmann, WE; Lum, JT; Piercey, MF; Svensson, K | 1 |
| Kameda, H; Watanabe, H | 1 |
2 other study(ies) available for sdz 208-912 and reserpine
| Article | Year |
|---|---|
Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study.
Topics: 4-Butyrolactone; Animals; Behavior, Animal; Brain; Dopamine; Dopamine Agents; Ergolines; Lisuride; Male; Motor Activity; Neurons; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Reserpine; Serotonin; Substantia Nigra; Time Factors | 1991 |
[SDZ HDC 912 as a dopamine receptor partial agonist: the effect on spontaneous locomotor activity in mice].
Topics: Administration, Oral; Animals; Dopamine Agents; Ergolines; Male; Mice; Mice, Inbred Strains; Motor Activity; Receptors, Dopamine; Reserpine | 1991 |